XBI
- SPDR S&P Biotech ETF关键资讯
| 最早日期 | 2006-02-06 |
ETF 资讯
| 基金提供者 | State Street |
| 指数 | S&P Biotechnology Select Industry |
| 费用率 | 0.35% |
| 持仓数量 | 140 |
| 成立日期 | 2006-01-31 |
| 资产类别 | Equity |
| 上市地 | US-listed |
| 产业 | Healthcare |
| 投资风格 | Growth |
| 非杠杆型 | Non-leveraged |
关于 XBI
The SPDR S&P Biotech ETF (XBI) provides exposure to the biotechnology sector in the United States, offering a diversified portfolio of mid-cap and small-cap securities. The fund tracks the S&P Biotechnology Select Industry Index, using an equal-weighted methodology to balance assets across all components. This ETF is suitable for investors seeking to fine-tune their exposure to the health care sector or those bullish on biotechnology over the long run.